Apple Fans Protest ...
Health Care: Drugs
Neuralstem Inc. (CUR: AMEX)
$1.19 0.03 | 2.59%
02/09/12 - 03:59 PM ET
94.00K / 77.50K
Vol / Avg. Vol:1.16 / 1.16
Open / Prev. Close:1.14 - 1.19
Today's Range:0.86 - 2.35
52 Wk Range:23.32%
Performance YTD:TheStreet Rating:
Portfolios with CUR
- Portfolio NameUser Type
- Userdennis diamonds
- UserMy Folly
- ContributorStem Cell Stocks
- UserRAPTOR SPRTD-0902092107
- UserBlogue's Picks
- Userbrownmark68 Portfolio 1
- UserBENIRANS II
- UserEnergy and Options
Latest CUR Headlines from TheStreet
- 9 Biotech Penny Stocks to Buy 08.31.10 | 10:08 am
- Interstate Hotel, Neuralstem: Midday Volume Plays 12.18.09 | 01:12 pm
- Four Must-See Charts: Stem Cell Stocks 07.02.09 | 03:07 pm
- Stem cell firms jump on Obama policy plans 03.06.09 | 06:03 pm
- Wednesday's Health Winners & Losers 09.19.07 | 04:09 pm
Press Releases for CUR
- Neuralstem President And CEO To Present At BIO CEO & Investor Conference 2012 - PR Newswire 02.08.12 | 09:02 am
- Neuralstem To Raise $5.2 Million In Registered Direct Offering - PR Newswire 02.06.12 | 09:02 am
- Diagnocure Announces Publication Of A Meta-analysis On Previstage(TM) GCC Colorectal Cancer Test - PR Newswire 01.26.12 | 07:01 am
- Neuralstem President And CEO To Update Ongoing ALS And NSI-189/Major Depressive Disorder Trials At 2012 Biotech Showcase - PR Newswire 01.09.12 | 01:01 pm
- DiagnoCure To Present At Biotech Showcase 2012 On January 11, 2012 - PR Newswire 01.09.12 | 07:01 am
- DiagnoCure To Host Q4 2011 And Full Year Earnings Conference Call And Webcast - PR Newswire 01.05.12 | 07:01 am
- Neuralstem's NSI-189 Trial In Major Depressive Disorder Receives FDA Approval To Advance To Phase Ib - PR Newswire 12.27.11 | 09:12 am
- First Patient Dosed In Cervical Region In Neuralstem ALS Stem Cell Trial - PR Newswire 11.23.11 | 09:11 am
- Neuralstem ALS Stem Cell Trial Featured On Fox Atlanta - PR Newswire 11.14.11 | 09:11 am
- Neuralstem Completes Phase Ia In Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial - PR Newswire 10.27.11 | 09:10 am
Partner Headlines for CUR
- End-of-Day Market Summary for November 23, 2011 - Benzinga 11.23.11 | 04:11 pm
- Neuralstem Loses $0.08/Share in Q2 - Seeking Alpha 08.11.11 | 09:08 am
- Zacks' Voice of the People highlights opportunities with Citigroup, Neuralstem, Primerica, PDL Biopharma - Press Releases - Zacks 04.28.10 | 09:04 am
- Data Mining - With Your OWN Spreadsheets - Voice of the People - Zacks 04.27.10 | 06:04 pm
